Traws Pharma, Inc. Earnings Per Share, Basic and Diluted
Traws Pharma, Inc. (TRAW) reported Earnings Per Share, Basic and Diluted of -$0.22 per share for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-11-15
- Traws Pharma, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.22.
- Traws Pharma, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.27.
- Traws Pharma, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.02.
- Traws Pharma, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.52.
- Traws Pharma, Inc. earnings per share, basic and diluted for fiscal 2020 was -$0.14.
- Traws Pharma, Inc. earnings per share, basic and diluted for fiscal 2019 was -$1.49.
- Traws Pharma, Inc. earnings per share, basic and diluted for fiscal 2018 was -$4.99.
- Traws Pharma, Inc. earnings per share, basic and diluted for fiscal 2017 was -$40.15.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-09-30 | -$0.22 10-Q · filed 2021-11-15 | -$0.80 10-Q · filed 2021-11-15 | ||||||
| 2021-06-30 | -$0.27 10-Q · filed 2021-08-16 | -$0.59 10-Q · filed 2021-08-16 | ||||||
| 2021-03-31 | -$0.02 10-Q · filed 2021-05-17 | |||||||
| 2020-12-31 | -$0.14 10-K · filed 2021-03-18 | |||||||
| 2020-09-30 | -$0.52 10-Q · filed 2021-11-15 | -$0.03 10-Q · filed 2020-11-16 | -$1.65 10-Q · filed 2021-11-15 | -$0.11 10-Q · filed 2020-11-16 | ||||
| 2020-06-30 | -$0.65 10-Q · filed 2021-08-16 | -$0.04 10-Q · filed 2020-08-12 | -$1.14 10-Q · filed 2021-08-16 | -$0.08 10-Q · filed 2020-08-12 | ||||
| 2020-03-31 | -$0.03 10-Q · filed 2021-05-17 | |||||||
| 2019-12-31 | -$1.49 10-K · filed 2021-03-18 | |||||||
| 2019-09-30 | -$0.75 10-Q · filed 2020-11-16 | -$2.63 10-Q · filed 2020-11-16 | ||||||
| 2019-06-30 | -$0.60 10-Q · filed 2020-08-12 | -$1.89 10-Q · filed 2020-08-12 | ||||||
| 2019-03-31 | -$1.29 10-Q · filed 2020-05-15 | |||||||
| 2018-12-31 | -$4.99 10-K · filed 2020-03-27 | |||||||
| 2018-09-30 | -$0.94 10-Q · filed 2019-11-12 | -$4.14 10-Q · filed 2019-11-12 | ||||||
| 2018-06-30 | -$1.10 10-Q · filed 2019-08-14 | -$0.07 10-Q · filed 2018-08-14 | -$3.76 10-Q · filed 2019-08-14 | -$0.25 10-Q · filed 2018-08-14 | ||||
| 2018-03-31 | -$5.04 10-Q · filed 2019-05-15 | -$0.34 10-Q · filed 2018-05-15 | ||||||
| 2017-12-31 | -$40.15 10-K · filed 2019-04-01 | -$2.68 10-K · filed 2018-03-16 | ||||||
| 2017-09-30 | -$10.60 10-Q · filed 2018-11-14 | -$0.71 10-Q · filed 2017-11-09 | -$31.37 10-Q · filed 2018-11-14 | -$2.09 10-Q · filed 2017-11-09 | ||||
| 2017-06-30 | -$0.29 10-Q · filed 2018-08-14 | -$1.38 10-Q · filed 2018-08-14 | ||||||
| 2017-03-31 | -$1.23 10-Q · filed 2018-05-15 | |||||||
| 2016-12-31 | -$4.44 10-K · filed 2018-03-16 | |||||||
| 2016-09-30 | -$0.29 10-Q · filed 2017-11-09 | -$3.90 10-Q · filed 2017-11-09 | ||||||
| 2016-06-30 | -$1.96 10-Q · filed 2017-08-14 | -$4.61 10-Q · filed 2017-08-14 | ||||||
| 2016-03-31 | -$2.65 10-Q · filed 2017-05-15 | -$0.27 10-Q · filed 2016-05-11 | ||||||
| 2015-12-31 | -$10.54 10-K · filed 2017-03-29 | -$1.05 10-K · filed 2016-03-28 | ||||||
| 2015-09-30 | -$2.60 10-Q · filed 2016-11-14 | -$0.26 10-Q · filed 2015-11-12 | -$12.35 10-Q · filed 2016-11-14 | -$1.23 10-Q · filed 2015-11-12 | ||||
| 2015-06-30 | -$4.13 10-Q · filed 2016-08-15 | -$0.41 10-Q · filed 2015-08-13 | -$9.81 10-Q · filed 2016-08-15 | -$0.98 10-Q · filed 2015-08-13 | ||||
| 2015-03-31 | -$0.57 10-Q · filed 2016-05-11 | |||||||
| 2014-12-31 | -$0.62 10-K · filed 2015-03-30 | -$1.30 derived: net income ÷ weighted average shares · filed 2015-11-12 | -$2.08 derived: net income ÷ weighted average shares · filed 2015-11-12 | -$2.94 10-K · filed 2016-03-28 | ||||
| 2014-09-30 | -$0.69 10-Q · filed 2015-11-12 | -$1.46 derived: net income ÷ weighted average shares · filed 2015-11-12 | -$2.32 10-Q · filed 2015-11-12 | -$3.01 derived: net income ÷ weighted average shares · filed 2015-11-12 | ||||
| 2014-06-30 | -$0.77 10-Q · filed 2015-08-13 | -$1.64 10-Q · filed 2015-08-13 | -$2.32 derived: net income ÷ weighted average shares · filed 2015-08-13 | -$3.54 derived: net income ÷ weighted average shares · filed 2015-08-13 | ||||
| 2014-03-31 | -$0.87 10-Q · filed 2015-05-15 | -$1.55 derived: net income ÷ weighted average shares · filed 2015-05-15 | -$2.78 derived: net income ÷ weighted average shares · filed 2015-05-15 | -$4.43 derived: net income ÷ weighted average shares · filed 2015-05-15 | ||||
| 2013-12-31 | -$0.68 10-K · filed 2015-03-30 | -$1.92 derived: net income ÷ weighted average shares · filed 2015-03-30 | -$3.72 derived: net income ÷ weighted average shares · filed 2015-03-30 | -$6.12 10-K · filed 2015-03-30 | ||||
| 2013-09-30 | -$1.34 10-K · filed 2015-03-30 | -$3.80 derived: net income ÷ weighted average shares · filed 2015-03-30 | -$7.23 10-Q · filed 2014-11-14 | -$10.70 derived: net income ÷ weighted average shares · filed 2015-03-30 | ||||
| 2013-06-30 | -$5.21 10-K · filed 2015-03-30 | -$11.29 10-Q · filed 2014-08-14 | -$16.24 derived: net income ÷ weighted average shares · filed 2015-03-30 | -$17.72 derived: net income ÷ weighted average shares · filed 2015-03-30 | ||||
| 2013-03-31 | -$6.08 10-K · filed 2015-03-30 | -$11.05 derived: net income ÷ weighted average shares · filed 2015-03-30 | -$12.43 derived: net income ÷ weighted average shares · filed 2015-03-30 | -$16.28 derived: net income ÷ weighted average shares · filed 2015-03-30 | ||||
| 2012-12-31 | -$4.89 10-K · filed 2014-03-20 | -$6.02 derived: net income ÷ weighted average shares · filed 2014-03-20 | -$9.85 derived: net income ÷ weighted average shares · filed 2014-03-20 | -$15.35 10-K · filed 2015-03-30 | ||||
| 2012-09-30 | -$1.02 10-K · filed 2014-03-20 | -$4.86 derived: net income ÷ weighted average shares · filed 2014-03-20 | -$10.36 10-Q · filed 2013-11-14 | |||||
| 2012-06-30 | -$3.84 10-K · filed 2014-03-20 | -$9.37 10-Q · filed 2013-09-06 | ||||||
| 2012-03-31 | -$5.53 10-K · filed 2014-03-20 | |||||||
| 2011-12-31 | -$14.18 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |